Carlsmed vs Lensar
CARL and LNSR side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CARL and LNSR compare
Carlsmed is the larger company, worth 5.7 times as much as Lensar ($408M against $71.7M).
Carlsmed grew revenue faster over the last twelve months (65.4% versus 3.3% for Lensar).
Lensar keeps more of each dollar of sales as profit, with a net margin of 57.6% compared with −57.4% at Carlsmed.
Lensar scores higher on the StockData Score (7 against 5 for Carlsmed), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CARL | LNSR |
|---|---|---|
| Size and price | ||
| Market cap | $408M | $71.7M |
| Share price | $14.95 | $5.84 |
| Change, 1 year | 19.5% | −50.9% |
| Change, 5 years | – | −19.4% |
| Beta (5Y) | 2.09 | 0.58 |
| Employees | 24 | 150 |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 0 | 2 (better) |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 6.4× | 1.2× (better) |
| P/B | 4.8× | 4.8× (better) |
| FCF yield | −8.5% | – |
| Fair value | $7.99 | $6.46 |
| Margin of safety | −87.2% | 9.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 65.4% (better) | 3.3% |
| Revenue growth, 5Y average | – | 17.2% |
| Profitability | ||
| Gross margin | 76.6% (better) | 48.3% |
| Operating margin | −61.1% | −13.5% (better) |
| Net margin | −57.4% | 57.6% (better) |
| FCF margin | −54.6% | – |
| Return on equity | −6197% | – |
| Financial health | ||
| Debt / equity | – | 0.25 |
| Interest coverage | −29.0× | – |
| Current ratio | 8.84 (better) | 2.39 |
| Altman Z-score | 6.23 (better) | −0.76 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 20.9% | 36.0% |
| Held by insiders | 81.1% | – |
| Insider net buying, 12 months | −$2.6M | – |
| Short interest, % of float | 20.4% | – |
Go deeper
- CARL stock overview
- CARL income statement
- CARL valuation and score
- LNSR stock overview
- LNSR income statement
- LNSR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.